Dry powder drug delivery system and methods
US9358352B2 · kind B2 · utility
1Cited by
424References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 2011 |
| Grant date | Jun 7, 2016 |
| Priority date | — |
| Expiry date | Feb 23, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2205/6081
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A pulmonary drug delivery system is disclosed, including a breath-powered, dry powder inhaler, and a cartridge for delivering a dry powder formulation. The inhaler and cartridge can be provided with a drug delivery formulation comprising, for example, a diketopiperazine and an active ingredient, including, small organic molecules, peptides and proteins, including, insulin and glucagon-like peptide 1 for the treatment of disease and disorders, for example, endocrine disease such as diabetes and/or obesity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.